Back to results
US 2023/0067644 A1Published application
Drg-mdm2-3 for use as a novel mouse double minute 2 (mdm2) inhibitor
AssigneeBahcesehir Universitesi
InventorsSerdar DURDAGI, Muge ORHAN, Timucin AVSAR, Maide PAKSOY, Gulsah AYDIN, Mine YURTSEVER
Life of this patent
Estimating the term…
Abstract
The invention relates to compound shown with formula (I) or a pharmaceutically acceptable derivative thereof for use as a novel inhibitor of MDM2 activity.
Claims13
A compound shown with formula I which is DRG-MDM2_3, or a pharmaceutically acceptable derivative thereof.
Dependencies are inferred from the claim text.